Expression of the Axd (axial defects) mutation in the mouse is insensitive to retinoic acid at low dose.
The Axd mutation in the mouse acts by an unknown mechanism to cause lumbosacral open neural tube defects and a variety of tail anomalies. Retinoic acid (RA) plays a number of different physiological and developmental roles and has been shown to affect neurulation in mice and other species. Indeed, reports have shown that this biologically active compound (or its metabolites) at low dose can alter the incidence of neural tube defects (NTD) in curly-tail (ct), splotch (Sp), and delayed splotch (Spd) mice, strains that are genetically predisposed to such abnormalities. The aim of the present study was to determine if RA administered under similar conditions would affect the penetrance or expression of the Axd mutation or survival of Axd homozygotes. Axd/+ and +/+ dams were exposed to RA intraperitoneally (5 mg/kg) on D9 postcoitus. No difference in incidence or extent of neural tube defects or other axial anomalies was detected among embryos of Axd/+ dams given RA compared with those administered vehicle only. This finding is consistent with the diversity of gene-controlled steps required for neurulation and the differing sensitivities of specific mutants to rescue by extrinsic agents.
Haviland
M B
MB
Department of Biological Sciences, Rutgers University, Piscataway, New Jersey 08855-1059.
Essien
F B
FB
D000818:Animals; D003433:Crosses, Genetic; D005260:Female; D015870:Gene Expression / Q000187:drug effects*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009154:Mutation; D009436:Neural Tube Defects / Q000235:genetics* / Q000517:prevention & control; D015996:Survival Rate; D013623:Tail / Q000002:abnormalities; D014212:Tretinoin / Q000494:pharmacology*
D014212:Tretinoin